<SEC-DOCUMENT>0001558370-20-002997-index.html : 20200320 <SEC-HEADER>0001558370-20-002997.hdr.sgml : 20200320 <ACCEPTANCE-DATETIME>20200320165419 ACCESSION NUMBER: 0001558370-20-002997 CONFORMED SUBMISSION TYPE: 424B5 PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20200320 DATE AS OF CHANGE: 20200320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TG THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B5 SEC ACT: 1933 Act SEC FILE NUMBER: 333-233636 FILM NUMBER: 20732617 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (212) 554-4484 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030310 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 </SEC-HEADER> <DOCUMENT> <TYPE>424B5 <SEQUENCE>1 <FILENAME>f424b5.htm <DESCRIPTION>424B5 <TEXT> Document 1 - file: f424b5.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>f424b5g001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: f424b5g001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>f424b5g002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: f424b5g002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>f424b5g003.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: f424b5g003.jpg
</DOCUMENT> </SEC-DOCUMENT>